What's new?

October 22, 2020 12:30 AM Eastern Daylight Time   PARIS--BUSINESS WIRE --Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (the "Company"), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative di...

CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”), a clinical-stage biopharmaceutical company developing medications targeting cardiovascular disease, announced today that they have dosed the first subject in the brigHTN study. The brigHTN study is a Phase 2 clinical trial evaluating the ...

Dr. Anderson’s appointment as Partner in the Crossover Fund reflects the venture capital firm’s continuing expansion across the entire value chain of life sciences investments, from seed to later-stage   PARIS, France – October 14, 2020 - Sofinnova Partners, a leading European life sciences venture capital firm bas...

Designation based on positive topline results from NATIVE Phase IIb clinical trial evaluating lanifibranor in non-alcoholic steatohepatitis (NASH) Lanifibranor believed to be the first drug candidate to receive Breakthrough Therapy designation in NASH since 2015 There are currently no FDA-approved treatments for th...

Paris, October 9th, 2020 - AFYREN, a biotechnology company producing bio-based ingredients and molecules for markets including cosmetics, food, feed, and fine chemicals, is pleased to announce the appointment of Stefan BORGAS as Chairman of its Board of Directors.   The appointment marks a key part of a strategic d...

Proven leader with deep worldwide ophthalmology experience, including multiple approvals globally   LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA thera...

For the first time, this event, which has been bringing together leading global VCs and biotech startups for over 20 years will be hosted in Milan.   Milan, Italy, October 1, 2020   The European House - Ambrosetti and Sofinnova Partners are pleased to announce that the city of Milan has been selected to host BioEqu...

Non-dilutive funding to support development of novel biocontrol against bacterial plant diseases   October 01, 2020 02:00 ET Source: Biotalys   GHENT, Belgium, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Biotalys NV, a transformative food and crop protection company, today announced that it has been awarded a €1.1 million re...

LAUSANNE, SWITZERLAND / AGILITYPR.NEWS / September 25, 2020 / RefleXion and Sofinnova Partners received the “Salus Partner Excellence in HealthTech Award” at the Convergence in Oncology Summit in Lausanne, Switzerland. The prize recognizes RefleXion and Sofinnova Partner’s vision and excellence in developing the di...

Montpellier, September 18, 2020 – Sensorion (FR0012596468 – ALSEN – the “Company”) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders announces today the success of its previously announce...